Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Janssen USA

Executive Summary

Larry Pickering to exec VP from general manager of Ortho's Dermatological Division. A press release on the promotion credits Pickering as "largely responsible for Retin-A's current development as a compound to treat photo-aged skin".

You may also be interested in...



Major Milestone For Diurnal As FDA Approves Alkindi

The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.

US FDA Personnel Costs Drop: Is The Next Generation Taking Over?

The agency sees its personnel compensation and benefits costs decrease for the first time in at least 16 years, while the overall FTE count continues to rise.

US FDA Simplifies Variance Application Process For X-Ray Companies

X-ray manufacturers and importers submitting Electronic Product Control reports will only need to submit their variance application package once.

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel